Editorial: Infliximab De-Escalation in Inflammatory Bowel Disease Using a Therapeutic Drug Monitoring Strategy - Early Promise but More Data Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Gastroenterology
HepatologyGastroenterology
2017English

Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2015English

Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Weighing the Global Risk of Cancer With Thiopurines in Inflammatory Bowel Disease-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Vedolizumab Drug Levels in Cord and Maternal Blood in Women With Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy